PATRICK GREGORY S
Insider CIK 1219844 · SUPN VP, Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise deriv | 2020-11-09 | 2020-11-10 | 5,000 | — | $0 | 10,000 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | S Sale | 2020-11-09 | 2020-11-10 | 5,000 | $25.00 | $125.0K | 44,463 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise | 2020-11-09 | 2020-11-10 | 5,000 | $12.98 | $64.9K | 49,463 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise deriv | 2020-11-05 | 2020-11-06 | 5,000 | — | $0 | 15,000 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise | 2020-11-05 | 2020-11-06 | 5,000 | $12.98 | $64.9K | 49,463 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | S Sale | 2020-11-05 | 2020-11-06 | 5,000 | $23.00 | $115.0K | 44,463 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise deriv | 2020-10-15 | 2020-10-15 | 15,000 | — | $0 | 20,000 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | S Sale | 2020-10-15 | 2020-10-15 | 15,000 | $20.03 | $300.4K | 44,463 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise | 2020-10-15 | 2020-10-15 | 15,000 | $12.98 | $194.7K | 59,463 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | G Gift | 2020-08-27 | 2020-08-28 | 1,120 | — | $0 | 44,463 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | G Gift | 2020-08-25 | 2020-08-28 | 1,000 | — | $0 | 45,583 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise deriv | 2020-05-20 | 2020-05-20 | 15,000 | — | $0 | 35,000 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | S Sale | 2020-05-20 | 2020-05-20 | 15,000 | $25.03 | $375.4K | 46,057 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise | 2020-05-20 | 2020-05-20 | 15,000 | $12.98 | $194.7K | 61,057 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise deriv | 2020-05-08 | 2020-05-11 | 15,000 | — | $0 | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | S Sale | 2020-05-08 | 2020-05-11 | 15,000 | $23.14 | $347.1K | 46,057 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise | 2020-05-08 | 2020-05-11 | 15,000 | $9.13 | $136.9K | 61,057 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2020-02-21 | 2020-02-25 | 50,000 | — | $0 | 50,000 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | G Gift | 2019-07-31 | 2019-08-01 | 2,590 | — | $0 | 45,682 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | M Exercise deriv | 2019-02-27 | 2019-02-28 | 20,000 | — | $0 | 15,000 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | M Exercise | 2019-02-27 | 2019-02-28 | 20,000 | $9.13 | $182.6K | 67,896 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | S Sale | 2019-02-27 | 2019-02-28 | 20,000 | $41.53 | $830.6K | 47,896 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | A Award deriv | 2019-02-22 | 2019-02-26 | 40,000 | — | $0 | 40,000 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | M Exercise deriv | 2018-07-02 | 2018-07-03 | 15,000 | — | $0 | 35,000 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | M Exercise deriv | 2018-07-02 | 2018-07-03 | 20,000 | — | $0 | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | M Exercise | 2018-07-02 | 2018-07-03 | 15,000 | $9.13 | $136.9K | 90,975 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | M Exercise | 2018-07-02 | 2018-07-03 | 20,000 | $9.24 | $184.8K | 75,975 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | S Sale | 2018-07-02 | 2018-07-03 | 35,000 | $56.63 | $1.98M | 55,975 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | A Award deriv | 2018-02-14 | 2018-02-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | M Exercise deriv | 2018-01-11 | 2018-01-12 | 20,000 | — | $0 | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | M Exercise deriv | 2018-01-11 | 2018-01-12 | 25,000 | — | $0 | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | M Exercise deriv | 2018-01-11 | 2018-01-12 | 30,000 | — | $0 | 20,000 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | S Sale | 2018-01-11 | 2018-01-12 | 50,000 | $43.56 | $2.18M | 55,975 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | M Exercise | 2018-01-11 | 2018-01-12 | 30,000 | $9.24 | $277.2K | 105,975 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | M Exercise | 2018-01-11 | 2018-01-12 | 20,000 | $7.90 | $158.0K | 75,975 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | M Exercise | 2018-01-11 | 2018-01-12 | 25,000 | $5.88 | $147.0K | 55,975 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | M Exercise deriv | 2017-09-08 | 2017-09-11 | 15,000 | — | $0 | 25,000 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | M Exercise deriv | 2017-09-08 | 2017-09-11 | 23,481 | — | $0 | 20,000 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | M Exercise | 2017-09-08 | 2017-09-11 | 23,481 | $7.90 | $185.5K | 39,197 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | M Exercise | 2017-09-08 | 2017-09-11 | 15,000 | $5.88 | $88.2K | 30,716 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | S Sale | 2017-09-08 | 2017-09-11 | 23,481 | $48.89 | $1.15M | 15,716 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | M Exercise deriv | 2017-09-07 | 2017-09-11 | 15,000 | — | $0 | 40,000 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | M Exercise deriv | 2017-09-07 | 2017-09-11 | 26,519 | — | $0 | 43,481 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | M Exercise | 2017-09-07 | 2017-09-11 | 26,519 | $7.90 | $209.5K | 27,235 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | S Sale | 2017-09-07 | 2017-09-11 | 25,000 | $46.36 | $1.16M | 2,235 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | M Exercise | 2017-09-07 | 2017-09-11 | 15,000 | $5.88 | $88.2K | 15,716 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | S Sale | 2017-09-07 | 2017-09-11 | 1,519 | $48.00 | $72.9K | 716 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | M Exercise deriv | 2017-04-24 | 2017-04-26 | 50,000 | — | $0 | 55,000 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | M Exercise | 2017-04-24 | 2017-04-26 | 50,000 | $5.88 | $294.0K | 54,221 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | S Sale | 2017-04-24 | 2017-04-26 | 54,000 | $32.37 | $1.75M | 221 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | A Award deriv | 2017-02-24 | 2017-02-27 | 50,000 | — | $0 | 50,000 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | S Sale | 2016-09-16 | 2016-09-16 | 2,000 | $25.00 | $50.0K | 3,616 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | S Sale | 2016-07-14 | 2016-07-15 | 3,395 | $22.00 | $74.7K | 5,616 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | A Award deriv | 2016-03-01 | 2016-03-03 | 50,000 | — | $0 | 50,000 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | S Sale | 2015-07-16 | 2015-07-16 | 6,217 | $20.00 | $124.3K | 7,344 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | A Award deriv | 2015-03-03 | 2015-03-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | A Award deriv | 2014-01-21 | 2014-01-23 | 50,000 | — | $0 | 50,000 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | P Buy | 2013-03-14 | 2013-03-15 | 5,000 | $6.95 | $34.8K | 8,903 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | A Award deriv | 2013-02-05 | 2013-02-07 | 70,000 | — | $0 | 70,000 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | P Buy | 2012-05-04 | 2012-05-07 | 3,000 | $5.00 | $15.0K | 3,000 | SEC↗ |